Economic Evaluation Of Diabetes (Type 2 Diabetes) Treated By Integrated Traditional Chinese And Western Medicine

There are four important evaluation factors for the use of drug:Safe, effective, economic and suitable,the research of economic evaluation is the weak aspect.drug economics evaluation can plan to provide the reference for the clinical treatment of disease, using the least amount of resources to achieve the best treatment effect, to find a balance between the costs and benefits, to better use of limited resources for hospital, reduce the waste of resources.Develop the cross-sectional retrospective survey in a hospital of traditional Chinese medicine, with the medical record of type2diabetes patients in hospital as the object of study.Use multiple linear stepwise regression analysis to study the factors that influence the cost, all factors that collected as fable actors, construction model and eliminate the minimal impact factors the gradually.Evaluate the rationality of drug use with detection index of the drug utilization index (DUI).Analysis treatment plan Combined traditional Chinese and Western Medicine with Cost effectiveness analysis of pharmacoeconomic.There are4factors were selected into the equation:the complications of diabetes, age, days of hospitalization, total number of complications.From the standardized partial regression coefficient of view,Multivariate linear stepwise regression, the regression equation:Y＝0.027X2+0.019X10+0.096X11+0.007X8+8.621The top five injection of traditional Chinese medicine are radix acanthopanacis Semticosi injection,sowthistle-leaf ixeris seedling injection, honghuahuang injection,Shenkang injection,gastrodin injection。The oral hypoglycemic agents use of Western medicine Sulfonylureas and double guanidine preparation more than58%, the value of DUI were all=<1.0Except Voglibose (yineng) is1.1The clinical treatment efficiency were analyzed statistically, there was no significant difference between the two group, so use analysis of CMA,the cost of TCM-VM group is1159.27, group VM is1211.48yuan;The clinical treatment efficiency were analyzed statistically, efficacy Optimal secrete50, aspart30, insulin Detemir three groups of treatment significantly, so the cost effect analysis. cost effectiveness of three therapeutic schemes of FBG group is as follows:55.25,76.48,61.60;2hPBG cost effectiveness of treatment plan of three group is as follows:57.84,69.82,68.44. The usage is basically reasonable. TCM-VM scheme is better than VM scheme from the analysis, the incremental cost-effectiveness,By diabetes (type2diabetes mellitus) inpatients medical records to analyze economics research, for the effective prevention of further deterioration of the disease, the use of Chinese and western medicine hypoglycemic drugs rationally, and optimizing the best treatment plan for reference, to help make a limited health resources fully and reasonable use.